This is a specific type of schizophrenia where someone has severe problems with movement and behavior. They might be very still, rigid, or move in unusual ways. It's a serious condition that needs medical treatment.
Every report comes from a Lived member, sent anonymously.
Have you tried Ativan (Lorazepam) for Catatonic Schizophrenia?
Catatonic schizophrenia describes schizophrenia in which catatonia is a prominent feature. Catatonia is a severe disturbance of movement, speech and behavior. A person may become still and unresponsive for hours (stupor), stop speaking (mutism), hold an unusual posture against gravity, resist being moved or instructed, or repeat another person's words or movements. Some people swing the other way, into restless, purposeless agitation. Intense fear often sits underneath the outward stillness. The name comes from an older system that divided schizophrenia into subtypes. Current diagnostic manuals (DSM-5 and ICD-11) dropped those subtypes because they were unreliable, and now record catatonia as a feature that can accompany schizophrenia. That change also reflects an important fact: catatonia is not unique to schizophrenia. It also occurs with depression, bipolar disorder, autism and a range of medical and neurological illnesses. Catatonia matters because it can become dangerous in its own right. Someone who stops moving, eating and drinking is at risk of dehydration, kidney injury, blood clots, pneumonia and pressure sores. It is also one of the more treatable situations in psychiatry when it is recognized.
No one knows exactly what causes schizophrenia. Genes, brain development and environmental factors all appear to play a role, and it most often begins between the late teens and about age 30. Why some people with schizophrenia develop catatonia and others do not is not well understood. What is clearer is that a catatonic episode can have a specific trigger that needs finding. Stopping some medicines suddenly, particularly clozapine or a benzodiazepine, can bring on catatonia. Infections of the brain, autoimmune encephalitis (where the immune system attacks the brain), thyroid disease, seizures and some drugs can produce catatonia that looks identical. For that reason, a new episode in someone with schizophrenia is not automatically assumed to be the schizophrenia alone.
Catatonia is diagnosed by observation. A clinician looks for at least three characteristic signs, such as stupor, mutism, rigid or held postures, resistance to movement or instructions, odd repetitive movements, or echoing speech and actions. Rating scales help clinicians check each sign systematically and track change. Because the person may not be able to speak, family members and others who know them are an important source of history, including recent medication changes and drug use. When it is unclear whether catatonia is present, clinicians may give a small dose of lorazepam, a sedative medicine, and watch what happens. A clear improvement within minutes to half an hour supports the diagnosis and points toward treatment. The second task is ruling out other causes. Depending on the situation, this can include blood and urine tests, a brain scan, an EEG (a recording of the brain's electrical activity) and a lumbar puncture to test spinal fluid for infection or autoimmune encephalitis. Clinicians also check for problems catatonia has already caused, such as dehydration or blood clots, and distinguish it from look-alikes such as neuroleptic malignant syndrome, a dangerous reaction to antipsychotic medicines.
Treatment has two aims at once: relieve the catatonia quickly and treat the illness behind it. Acute catatonia is usually managed in hospital, where staff can also give fluids, nutrition, blood clot prevention and pressure care while the person cannot look after themselves. The first-line medicine is a benzodiazepine, usually lorazepam (Ativan), given by mouth, under the tongue or by injection. In acute catatonia the response can be striking, sometimes within minutes, and some people need gradually increased doses over several days. Once the catatonia resolves, lorazepam is tapered slowly. Stopping it abruptly can bring catatonia back and risks withdrawal seizures. Electroconvulsive therapy (ECT), a series of brief, controlled seizures induced under general anesthesia, is usually highly effective for catatonia. It is used when lorazepam does not work, or first when the situation is severe. Its main trade-offs are the anesthetic, temporary confusion after sessions and some loss of memory for events around the treatment period. Catatonia linked to schizophrenia, especially long-standing milder catatonia, tends to respond less well to lorazepam than catatonia linked to mood disorders, so ECT is used more often. For chronic catatonia in schizophrenia, clozapine (Clozaril), an antipsychotic reserved for schizophrenia that has not responded to other medicines, has some supporting evidence. It requires regular blood tests because it can cause a dangerous drop in infection-fighting white blood cells. If catatonia followed stopping clozapine, restarting it is often the first consideration. Antipsychotics remain the foundation of long-term schizophrenia treatment, but during active catatonia they are used with caution because catatonia raises the risk of neuroleptic malignant syndrome. Psychotherapy, family education, rehabilitation and skills training support recovery once the acute episode settles. Much of the evidence for catatonia treatment comes from small observational studies rather than large trials, so plans are adjusted to how each person responds.
Acute catatonia often improves substantially with treatment, sometimes over days. Chronic catatonia in schizophrenia tends to be more persistent and may improve only partly. Earlier treatment appears to work better than delayed treatment. Many people in catatonia are aware of what is happening around them and remember it later, even when they cannot respond. Speaking to the person directly and calmly, and explaining what is being done, matters for that reason. After an episode, ongoing care centers on schizophrenia itself: continuing medication, regular follow-up with a psychiatric team, and support with work, housing, relationships and daily routines. Catatonia can return, so people and families benefit from knowing the early signs that preceded an episode and from a plan agreed with the care team. Any change to lorazepam, clozapine or antipsychotic medicines is best made with the prescriber, since abrupt stops can trigger relapse.
Contact the psychiatric care team promptly if someone with schizophrenia becomes unusually still, stops speaking, holds odd postures, resists movement or shows new purposeless agitation, so that catatonia can be assessed and treated early. Seek same-day medical assessment if the person is not eating or drinking, has stopped responding, or has been immobile for long periods, because dehydration and other complications can develop quickly. Catatonia accompanied by fever, marked muscle stiffness, a racing heart, heavy sweating, swings in blood pressure or growing confusion needs emergency medical care. These signs can mean malignant catatonia or neuroleptic malignant syndrome, both of which can be fatal without urgent treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Catatonic Schizophrenia is like, what's helped you, or ask the community a question.